Thursday, November 27, 2014

I was excited for LBP3, but lost interest after learning that Media Molecule wasnt developing it. Same goes for Bloodbor

I was excited for LBP3, but lost interest after learning that Media Molecule wasnt developing it. Same goes for Bloodbor